Suppr超能文献

流感疫苗和肺炎球菌疫苗能否预防糖尿病老年人的社区获得性呼吸道感染?这在慢性肾脏病患者中是否存在差异?一项使用电子健康记录的队列研究。

Do influenza and pneumococcal vaccines prevent community-acquired respiratory infections among older people with diabetes and does this vary by chronic kidney disease? A cohort study using electronic health records.

作者信息

McDonald Helen I, Thomas Sara L, Millett Elizabeth R C, Quint Jennifer, Nitsch Dorothea

机构信息

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

出版信息

BMJ Open Diabetes Res Care. 2017 Apr 3;5(1):e000332. doi: 10.1136/bmjdrc-2016-000332. eCollection 2017.

Abstract

OBJECTIVE

We aimed to estimate the effectiveness of influenza and 23-valent pneumococcal polysaccharide vaccination on reducing the burden of community-acquired lower respiratory tract infection (LRTI) among older people with diabetes, and whether this varied by chronic kidney disease (CKD) status.

RESEARCH DESIGN AND METHODS

We used linked UK electronic health records for a retrospective cohort study of 190 492 patients ≥65 years with diabetes mellitus and no history of renal replacement therapy, 1997-2011. We included community-acquired LRTIs managed in primary or secondary care. Infection incidence rate ratios were estimated using the Poisson regression. Pneumococcal vaccine effectiveness (VE) was calculated as (1-effect measure). To estimate influenza VE, a ratio-of-ratios analysis (winter effectiveness/summer effectiveness) was used to address confounding by indication. Final VE estimates were stratified according to estimated glomerular filtration rate and proteinuria status.

RESULTS

Neither influenza nor pneumococcal vaccine uptake varied according to CKD status. Pneumococcal VE was 22% (95% CI 11% to 31%) against community-acquired pneumonia for the first year after vaccination, but was negligible after 5 years. In the ratio-of-ratios analysis, current influenza vaccination had 7% effectiveness for preventing community-acquired LRTI (95% CI 3 to 12). Pneumococcal VE was lower among patients with a history of proteinuria than among patients without proteinuria (p=0.04), but otherwise this study did not identify variation in pneumococcal or influenza VE by markers of CKD.

CONCLUSIONS

The public health benefits of influenza vaccine may be modest among older people with diabetes. Pneumococcal vaccination protection against community-acquired pneumonia declines swiftly: alternative vaccination schedules should be investigated.

摘要

目的

我们旨在评估流感疫苗和23价肺炎球菌多糖疫苗在减轻糖尿病老年人社区获得性下呼吸道感染(LRTI)负担方面的有效性,以及这种有效性是否因慢性肾脏病(CKD)状态而异。

研究设计与方法

我们使用英国的关联电子健康记录,对1997年至2011年期间190492例年龄≥65岁、患有糖尿病且无肾脏替代治疗史的患者进行回顾性队列研究。我们纳入了在初级或二级医疗中管理的社区获得性LRTI。使用泊松回归估计感染发病率比。肺炎球菌疫苗效力(VE)计算为(1 - 效应量)。为了估计流感疫苗效力,采用比值比分析(冬季效力/夏季效力)来解决指征性混杂问题。最终的疫苗效力估计值根据估计的肾小球滤过率和蛋白尿状态进行分层。

结果

流感疫苗和肺炎球菌疫苗的接种率均未因CKD状态而有所不同。接种疫苗后的第一年,肺炎球菌疫苗对社区获得性肺炎的效力为22%(95%CI 11%至31%),但5年后可忽略不计。在比值比分析中,当前接种流感疫苗预防社区获得性LRTI的效力为7%(95%CI 3%至12%)。有蛋白尿病史的患者中肺炎球菌疫苗效力低于无蛋白尿的患者(p = 0.04),但除此之外,本研究未发现肺炎球菌或流感疫苗效力因CKD标志物而存在差异。

结论

流感疫苗对糖尿病老年人的公共卫生益处可能有限。肺炎球菌疫苗对社区获得性肺炎的保护作用迅速下降:应研究替代接种方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验